StockData
Pfizer Inc logo

Pfizer Inc

PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026Score 11/3053% above fair value
$30.67+0.15 (+0.49%)

Close on Nov 2, 2026Market cap $174.81BP/E 40.4Yield 5.61%

Pfizer Cencora, Inc. (formerly AmerisourceBergen) by Year

Cencora, Inc. (formerly AmerisourceBergen) — Share of consolidated total revenues (%) (%)

Pfizer Cencora, Inc. (formerly AmerisourceBergen): 16.0% in FY2025, down 1.0 pts from a year earlier.

Latest, FY2025
16.0%
Period ended Dec 31, 2025
Change on a year earlier
-1.0 pts
17.0% in FY2024
History
9 years
Since FY2017
Sources
7
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-K (filed 2026-02-26) ↗

Reported in Form 10-K Note 17 — Significant Customers & Geographic Concentration.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCencora, Inc. (formerly AmerisourceBergen) — Share of consolidated total revenues (%) (%)Year on yearSource
FY2025Dec 31, 202516.0%-1.0 ptsForm 10-K (filed 2026-02-26) ↗
FY2024Dec 31, 202417.0%+5.0 ptsForm 10-K (filed 2026-02-26) ↗
FY2023Dec 31, 202312.0%+7.0 ptsForm 10-K (filed 2026-02-26) ↗
FY2022Dec 31, 20225.0%-2.0 ptsForm 10-K (filed 2025-02-27) ↗
FY2021Dec 31, 20217.0%-7.0 ptsForm 10-K (filed 2024-02-22) ↗
FY2020Dec 31, 202014.0%+3.0 ptsForm 10-K (filed 2023-02-23) ↗
FY2019Dec 31, 201911.0%+3.0 ptsForm 10-K (filed 2022-02-24) ↗
FY2018Dec 31, 20188.0%-4.0 ptsForm 10-K (filed 2021-02-25) ↗
FY2017Dec 31, 201712.0%–Form 10-K (filed 2020-02-27) ↗

Cite this data

StockData. (2026). Pfizer Cencora, Inc. (formerly AmerisourceBergen) (%), annual FY2017–FY2025 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/conc-cencora

See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.